148 related articles for article (PubMed ID: 8997167)
21. Bone mineral density: serum markers of bone turnover and their relationships in peritoneal dialysis.
Negri AL; Barone R; Quiroga MA; Bravo M; Marino A; Fradinger E; Bogado CE; Zanchetta JR
Perit Dial Int; 2004; 24(2):163-8. PubMed ID: 15119637
[TBL] [Abstract][Full Text] [Related]
22. The relationship between intact PTH and biointact PTH (1-84) with bone and mineral metabolism in pre-dialysis chronic kidney disease (CKD).
O'Flaherty D; Sankaralingam A; Scully P; Manghat P; Goldsmith D; Hampson G
Clin Biochem; 2013 Oct; 46(15):1405-9. PubMed ID: 23830844
[TBL] [Abstract][Full Text] [Related]
23. Vitamin D status in female patients with primary hyperparathyroidism: does it play a role in skeletal damage?
Carnevale V; Manfredi G; Romagnoli E; De Geronimo S; Paglia F; Pepe J; Scillitani A; D'Erasmo E; Minisola S
Clin Endocrinol (Oxf); 2004 Jan; 60(1):81-6. PubMed ID: 14678292
[TBL] [Abstract][Full Text] [Related]
24. [Bone density and laboratory parameters of bone metabolism in patients with terminal heart disease].
Christ E; Linka A; Junga G; Odermatt M; Steinert H; Kiowski W; Schmid C
Schweiz Med Wochenschr; 1996 Sep; 126(37):1553-9. PubMed ID: 8927958
[TBL] [Abstract][Full Text] [Related]
25. Skeletal status in adolescents with end-stage renal failure: a longitudinal study.
Pluskiewicz W; Adamczyk P; Drozdzowska B; Szprynger K; Szczepańska M; Halaba Z; Karasek D
Osteoporos Int; 2005 Mar; 16(3):289-95. PubMed ID: 15221204
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the humoral markers of bone turnover and bone mineral density in patients on haemodialysis and continuous ambulatory peritoneal dialysis.
Hampson G; Vaja S; Evans C; Chesters CA; Pettit R; Evans W; Thomas D; Seed PT; Fraser WD
Nephron; 2002 May; 91(1):94-102. PubMed ID: 12021525
[TBL] [Abstract][Full Text] [Related]
27. Function of parathyroid glands in kidney transplant patients--diagnostic value of CAP and CIP.
Spiechowicz U; Kokot F; Wiecek A
Ann Transplant; 2004; 9(3):33-6. PubMed ID: 15759544
[TBL] [Abstract][Full Text] [Related]
28. Bone mineral disorders in pediatric and adolescent renal transplant recipients.
Derakhshan A; Behbahan AG; Lotfi M; Omrani GH; Fallahzadeh MH; Basiratnia M; Al-Hashemi GH
Pediatr Transplant; 2011 Jun; 15(4):367-75. PubMed ID: 21429060
[TBL] [Abstract][Full Text] [Related]
29. Body composition and muscle strength in healthy men receiving testosterone enanthate for contraception.
Young NR; Baker HW; Liu G; Seeman E
J Clin Endocrinol Metab; 1993 Oct; 77(4):1028-32. PubMed ID: 8408450
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients--a single-center cohort study.
Iimori S; Mori Y; Akita W; Kuyama T; Takada S; Asai T; Kuwahara M; Sasaki S; Tsukamoto Y
Nephrol Dial Transplant; 2012 Jan; 27(1):345-51. PubMed ID: 21652550
[TBL] [Abstract][Full Text] [Related]
31. Correlation of bone mineral density with the histological findings of renal osteodystrophy in patients on hemodialysis.
Gerakis A; Hadjidakis D; Kokkinakis E; Apostolou T; Raptis S; Billis A
J Nephrol; 2000; 13(6):437-43. PubMed ID: 11132760
[TBL] [Abstract][Full Text] [Related]
32. [Hemodialysis with 2.5 mEq/L of calcium in relative hypoparathyroidism: long-term effects on bone mass].
Sánchez Perales MC; García Cortés MJ; Borrego FJ; Fernández Martínez S; Borrego J; Pérez del Barrio P; Liébana A; Pérez Bañasco V
Nefrologia; 2000; 20(3):254-61. PubMed ID: 10917002
[TBL] [Abstract][Full Text] [Related]
33. Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism.
Rossini M; Gatti D; Isaia G; Sartori L; Braga V; Adami S
J Bone Miner Res; 2001 Jan; 16(1):113-9. PubMed ID: 11149474
[TBL] [Abstract][Full Text] [Related]
34. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
35. Bone turnover markers are associated with bone density, but not with fracture in end stage kidney disease: a cross-sectional study.
Jørgensen HS; Winther S; Bøttcher M; Hauge EM; Rejnmark L; Svensson M; Ivarsen P
BMC Nephrol; 2017 Sep; 18(1):284. PubMed ID: 28874132
[TBL] [Abstract][Full Text] [Related]
36. Risk factors for diminished bone mineral density among male hemodialysis patients--a cross-sectional study.
Mirfakhraee S; Sakhaee K; Zerwekh J; Adams-Huet B; Gruntmanis U
Arch Osteoporos; 2012; 7():283-90. PubMed ID: 23152064
[TBL] [Abstract][Full Text] [Related]
37. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women: a randomized clinical trial.
Greenspan SL; Parker RA; Ferguson L; Rosen HN; Maitland-Ramsey L; Karpf DB
J Bone Miner Res; 1998 Sep; 13(9):1431-8. PubMed ID: 9738515
[TBL] [Abstract][Full Text] [Related]
38. Femoral neck osteopenia in patients with inflammatory bowel disease.
Pollak RD; Karmeli F; Eliakim R; Ackerman Z; Tabb K; Rachmilewitz D
Am J Gastroenterol; 1998 Sep; 93(9):1483-90. PubMed ID: 9732930
[TBL] [Abstract][Full Text] [Related]
39. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial.
Lips P; Duong T; Oleksik A; Black D; Cummings S; Cox D; Nickelsen T
J Clin Endocrinol Metab; 2001 Mar; 86(3):1212-21. PubMed ID: 11238511
[TBL] [Abstract][Full Text] [Related]
40. Longitudinal changes in bone mineral density and bone turnover in postmenopausal women with primary hyperparathyroidism.
Guo CY; Thomas WE; al-Dehaimi AW; Assiri AM; Eastell R
J Clin Endocrinol Metab; 1996 Oct; 81(10):3487-91. PubMed ID: 8855790
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
